US Stock MarketDetailed Quotes

ACRS Aclaris Therapeutics

Watchlist
  • 1.270
  • +0.080+6.72%
Close Apr 24 16:00 ET
  • 1.270
  • 0.0000.00%
Post 16:05 ET
137.35MMarket Cap-0.74P/E (TTM)

Aclaris Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Aclaris Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 4 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q2-- / 3.625M--
--2025/Q1-- / 3.550M--
--2024/Q49.211M / 7.041M--
--2024/Q34.346M / 11.849M--
--2024/Q22.766M / 1.817M--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q2-- / 3.625M--
--2025/Q1-- / 3.550M--
--2024/Q49.211M / 7.041M--
--2024/Q34.346M / 11.849M--
--2024/Q22.766M / 1.817M--

Unlock Free Earnings Estimates

Aclaris Therapeutics Earnings Reports

  • Aclaris Therapeutics | 10-K: FY2024 Annual Report

    Feb 27 16:31 ET

  • Aclaris Therapeutics | 8-K: Aclaris Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides a Corporate Update

    Feb 27 07:18 ET

  • Aclaris Therapeutics | 10-Q: Q3 2024 Earnings Report

    Nov 6, 2024 16:34 ET

  • Aclaris Therapeutics | 8-K: Aclaris Therapeutics Reports Third Quarter 2024 Financial Results and Provides a Corporate Update

    Nov 6, 2024 07:22 ET

    • Read more

    Market Insights

    Top Gaining Chinese Stocks Top Gaining Chinese Stocks
    No. Symbol % Chg
    Giansun Precision Technology Group
    001400
    +78.53%
    Heilongjiang Tianyouwei Electronics
    603202
    +24.06%
    Joy Kie Corporation
    300994
    +20.03%
    4
    Kingchem
    301509
    +20.02%
    5
    Hunan Er-kang Pharmaceutical
    300267
    +20.00%
    Log In for the Full List
    Unlock Now

    Investment Course

    Top 5 Industries for Stock Trading under Trump's Second Term
    Stocks & Industries to Watch Under Trump's Second Presidency
    With mooomoo, find out which stocks and industries may benefit from Trump's second presidency, based on his first administration's track record.

    Discussing

    Trade war escalates: What’s next for Chinese stocks?
    🎙️Discussion 1. China-EU EV negotiations kick off recently. How do you think the negotiations will impact the performance of related stocks Show More
    Alibaba Q4 FY2024 Earnings Preview: Predict & Win Big! 🚀

    Monetary Policy: Navigating the Fed's Rate Cut Cycle

    Changing Fed policy is altering the market math for investors.